Literature DB >> 14623928

Identification of c-Jun as bcl-2 transcription factor in human uterine endometrium.

Z L Li1, H Abe, K Ueki, K Kumagai, R Araki, Y Otsuki.   

Abstract

We describe the application of the biomolecular interaction (BIA) technique to detection of the interaction between protein (e.g., c-Jun) and DNA (e.g., two AP-1 motifs from bcl-2 promoter), compared with immunohistochemistry (IHC) of c-Jun. The specific binding assay for the interaction of c-Jun and activating protein-1 (AP-1) motifs was performed using a Biacore 2000 system. Intense immunoreactivity of c-Jun in glandular cells of the human uterine endometrium was observed in the proliferative phase, while c-Jun in stromal cells was expressed throughout the menstrual cycle. In contrast to the IHC of c-Jun, the specific binding of c-Jun to two separate AP-1 motifs in the bcl-2 promoter region was detected only in nuclear extracts of glandular cells, but not in stromal cells, during the proliferative phase. These results indicate that, while transmitting various signals, c-Jun enhances the transcription level of bcl-2, which in turn keeps glandular cells alive and proliferating in normal human endometrium during the proliferative phase. Moreover, the method involving real-time biomolecular interactions such as DNA-protein binding is novel for the study of transcription factors when combined with IHC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623928     DOI: 10.1177/002215540305101204

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  7 in total

Review 1.  A portable surface plasmon resonance sensor system for real-time monitoring of small to large analytes.

Authors:  Scott D Soelberg; Timothy Chinowsky; Gary Geiss; Charles B Spinelli; Richard Stevens; Steve Near; Peter Kauffman; Sinclair Yee; Clement E Furlong
Journal:  J Ind Microbiol Biotechnol       Date:  2005-11-11       Impact factor: 3.346

2.  Apoptotic effects of Tian-Long compound on endometrial adenocarcinoma cells in vitro.

Authors:  Zhong-Lian Li; Syoko Morishima; Jin-Tian Tang; Yoshinori Otsuki
Journal:  Med Mol Morphol       Date:  2009-03-18       Impact factor: 2.309

3.  Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β0-Thalassemia Families with High Fetal Hemoglobin Levels.

Authors:  Nicoletta Bianchi; Lucia Carmela Cosenza; Ilaria Lampronti; Alessia Finotti; Giulia Breveglieri; Cristina Zuccato; Enrica Fabbri; Giovanni Marzaro; Adriana Chilin; Gioia De Angelis; Monica Borgatti; Cristiano Gallucci; Cecilia Alfieri; Michela Ribersani; Antonella Isgrò; Marco Marziali; Javid Gaziev; Aldo Morrone; Pietro Sodani; Guido Lucarelli; Roberto Gambari; Katia Paciaroni
Journal:  Mol Diagn Ther       Date:  2016-04       Impact factor: 4.074

4.  The elevated activation of NFκB and AP-1 is correlated with differential regulation of Bcl-2 and associated with oral squamous cell carcinoma progression and resistance.

Authors:  Manzar Alam; Tanushree Kashyap; Kamdeo K Pramanik; Abhay K Singh; Siddavaram Nagini; Rajakishore Mishra
Journal:  Clin Oral Investig       Date:  2017-02-23       Impact factor: 3.573

5.  Regulation of bcl-2 transcription by estrogen receptor-α and c-Jun in human endometrium.

Authors:  Zhong-Lian Li; Ken Ueki; Koji Kumagai; Ryoji Araki; Yoshinori Otsuki
Journal:  Med Mol Morphol       Date:  2013-05-11       Impact factor: 2.309

6.  Pramanicin analog induces apoptosis in human colon cancer cells: critical roles for Bcl-2, Bim, and p38 MAPK signaling.

Authors:  Cagri Bodur; Ozgur Kutuk; Gizem Karsli-Uzunbas; Tayirjan T Isimjan; Paul Harrison; Huveyda Basaga
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

7.  MAPK/c-Jun signaling pathway contributes to the upregulation of the anti-apoptotic proteins Bcl-2 and Bcl-xL induced by Epstein-Barr virus-encoded BARF1 in gastric carcinoma cells.

Authors:  Yuqiong Zhang; Meiqin Xu; Xueyi Zhang; Fuying Chu; Tianji Zhou
Journal:  Oncol Lett       Date:  2018-03-19       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.